BLACKROCK Municipal Income TRUST V.BFK.P

Primary Symbol: BFK

BlackRock Municipal Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income taxes. Under normal market conditions, the Fund invests at least 80% of its managed assets in investments the income from which is exempt from federal income tax (except that the interest may be subject to the alternative minimum tax). The Fund may invest directly in securities or synthetically through the use of derivatives. The Fund's investment policies provide that it invests at least 80% of its total assets in investment grade quality municipal obligations issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies or instrumentalities, each of which pays interest that, in the opinion of bond counsel to the issuer, is excludable from gross income for federal income tax purposes. Its investment adviser is BlackRock Advisors, LLC.

NYSE:BFK - Post by User

BLACKROCK Municipal Income TRUST > cibc

<< Previous

Bullboard Posts

Next >>

Comment by Keeleron Oct 31, 2021 6:36pm

77 Views

Post# 34071314

RE:cibc

vulcan123456789 - (10/31/2021 5:15:29 PM)
cibc

even after friday.. on fri gave outperform rating and target of 5.00...

Right. We went thru this - apparently Zamparo isnt very good at guessing at Hexo's 12 month price target.
And again, CIBC and BMO are involved in Hexo financings - and possibly a bit biased in their opinion.

CIBC sees bull case for HEXO following acquisition, upgrades shares to outperformer

Feb. 17, 2021 7:33 AM ETHEXO Corp. (HEXO), ZBISFHEXO, ZBISFBy: Jonathan M Block, SA News Editor1 Comment

CIBC analyst John Zamparo has upgraded shares of HEXO Corp. (NYSE:HEXO) to outperformer and more than doubles his price target from C$5.60 to C$13.50.
Zamparo cites HEXO's $235M acquisition of Zenabis Global (OTCPK:ZBISF), announced yesterday, as a major catalyst.
He says that Zenabis should being in at least an extra $60M in revenue.
For HEXO, Zamparo estimates fiscal 2022 sales of $240M and fiscal 2023 sales of $300M.
He adds that cost synergies make Canadian cannabis M&A work and those synergies apply "to virtually anyone in the cannabis space."
Zamparo says that HEXO's multiple is below its peers and Zenabis gives the company much greater exposure to international markets.